| “I probably shouldn’t go in today”: Inequitable access to paid sick leave and its impacts on health behaviors during the emergence of COVID-19 in the Seattle area CD Iwu, SN Cox, SL Sohlberg, AE Kim, J Logue, PD Han, TR Sibley, ... PloS one 19 (9), e0307734, 2024 | | 2024 |
| CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation D Zamora, H Xie, A Sadowska-Klasa, E Kampouri, MA Biernacki, ... Blood Advances 8 (17), 4568-4580, 2024 | | 2024 |
| Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy vs. prophylaxis D Zamora, S Dasgupta, T Stevens-Ayers, B Edmison, DJ Winston, ... JCI insight, 2024 | | 2024 |
| Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study MD Fischer, ML Green, S Selke, AP Limaye, A Wald, MJ Boeckh, ... Transplant Infectious Disease, e14335, 2024 | | 2024 |
| Absenteeism and Health Behavior Trends Associated With Acute Respiratory Illness Before and During the COVID-19 Pandemic in a Community Household Cohort, King County, Washington E Chung, Y Wang, EJ Chow, A Emanuels, J Heimonen, CE Ogokeh, ... AJPM focus 3 (4), 100248, 2024 | | 2024 |
| Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients E Kampouri, EM Krantz, H Xie, SS Ibrahimi, ES Kiem, MK Sekhon, ... Blood 144 (5), 490-495, 2024 | 1 | 2024 |
| Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From … P Ljungman, RF Chemaly, F Khawaya, S Alain, R Avery, C Badshah, ... Clinical Infectious Diseases, ciae321, 2024 | 1 | 2024 |
| Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques A Sadowska-Klasa, S Özkök, H Xie, W Leisenring, D Zamora, S Seo, ... Blood Advances 8 (14), 3639-3651, 2024 | 2 | 2024 |
| How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic M Boeckh, SA Pergam, AP Limaye, J Englund, L Corey, JA Hill Clinical Infectious Diseases, ciae308, 2024 | | 2024 |
| Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation With Cytomegalovirus Disease A Sadowska-Klasa, WM Leisenring, AP Limaye, M Boeckh The Journal of Infectious Diseases 229 (5), 1435-1439, 2024 | 8 | 2024 |
| The effect of gastrointestinal graft-versus-host disease and diarrhea on the pharmacokinetic profile of sotrovimab in hematopoietic stem cell transplant recipients J Boonyaratanakornkit, Q Wang, A Nader, L Kimball, T Stevens-Ayers, ... The Journal of Infectious Diseases, jiae236, 2024 | 1 | 2024 |
| Respiratory Viral Infections and Diagnosis of Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplant M Vo, MB Peha, K Baker, C Bockner, G Yanik, H Sharifi, J Hsu, T Gooley, ... B47. LUNG TRANSPLANT, A3716-A3716, 2024 | | 2024 |
| Integrating Infectious Disease Advanced Practice Providers in the Workforce: An Educational Step Forward LH Yoke, M Boeckh, AM Beieler Open Forum Infectious Diseases, ofae232, 2024 | | 2024 |
| The impact of pre-transplant respiratory virus detection on post-transplant outcomes in children undergoing hematopoietic cell transplantation SR Kim, A Nordlander, H Xie, YJ Kim, C Ogimi, MS Thakar, W Leisenring, ... Clinical Infectious Diseases, ciae216, 2024 | | 2024 |
| Cytomegalovirus (CMV) reactivation and CMV-specific cell-mediated immunity after chimeric antigen receptor T-cell therapy E Kampouri, SS Ibrahimi, H Xie, ER Wong, JB Hecht, MK Sekhon, A Vo, ... Clinical Infectious Diseases 78 (4), 1022-1032, 2024 | 9 | 2024 |
| Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting … N Rashid, T Gooley, M Boeckh, MU Oshima, JH Chao, IB Hirsch, ... Transplantation and Cellular Therapy 30 (4), 417. e1-417. e9, 2024 | 1 | 2024 |
| Comparative diagnostic utility of SARS-CoV-2 rapid antigen and molecular testing in a community setting AE Kim, JC Bennett, K Luiten, JA O’Hanlon, CR Wolf, A Magedson, ... The Journal of Infectious Diseases, jiae150, 2024 | | 2024 |
| Evaluation of Three Cytomegalovirus IgG Lateral Flow Assays for Rapid Determination of CMV Serostatus L Joncas-Schronce, F Ali, G Pepper, RD Stapleton, GD Rubenfeld, ... Open Forum Infectious Diseases 11 (3), ofae084, 2024 | | 2024 |
| Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre–Cellular Therapy Severe Acute Respiratory Syndrome Coronavirus 2 … I Nimgaonkar, LH Yoke, P Roychoudhury, PW Flaherty, MU Oshima, ... Clinical Infectious Diseases, ciae116, 2024 | 6 | 2024 |
| Serial quantitation of plasma microbial cell-free DNA before and after diagnosis of pulmonary invasive mold infections after hematopoietic cell transplant MR Heldman, AA Ahmed, W Liu, A Vo, J Keane-Candib, T Stevens-Ayers, ... The Journal of Infectious Diseases 229 (2), 576-587, 2024 | 13 | 2024 |
Janet A EnglundProfessor of Pediatrics, University of Washington在 seattlechildrens.org 的电子邮件经过验证
